Joe Putnam
Faculty Member
Last active: 3/27/2014

  1. Irinotecan/cisplatin followed by 5-FU/paclitaxel/radiotherapy and surgery in esophageal cancer. Ajani JA, Faust J, Yao J, Komaki R, Stevens C, Swisher S, Putnam JB, Vaporciyan A, Smythe R, Walsh G, Rice D, Roth J (2003) Oncology (Williston Park) 17(9 Suppl 8): 20-2
    › Primary publication · 14569843 (PubMed)
  2. Induction treatment before surgery for non-small cell lung cancer. Eberhardt WE, Albain KS, Pass H, Putnam JB, Gregor A, Assamura H, Mornex F, Senan S, Belderbos J, Westeel V, Thomas M, Van Schil P, Vansteenkiste J, Manegold C, Mirimanoff RO, Stuschke M, Pignon J, Rocmans P, Shepherd FA (2003) Lung Cancer : S9-14
    › Primary publication · 14708516 (PubMed)
  3. Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy. Swisher SG, Roth JA, Komaki R, Gu J, Lee JJ, Hicks M, Ro JY, Hong WK, Merritt JA, Ahrar K, Atkinson NE, Correa AM, Dolormente M, Dreiling L, El-Naggar AK, Fossella F, Francisco R, Glisson B, Grammer S, Herbst R, Huaringa A, Kemp B, Khuri FR, Kurie JM, Liao Z, McDonnell TJ, Morice R, Morello F, Munden R, Papadimitrakopoulou V, Pisters KM, Putnam JB, Sarabia AJ, Shelton T, Stevens C, Shin DM, Smythe WR, Vaporciyan AA, Walsh GL, Yin M (2003) Clin Cancer Res 9(1): 93-101
    › Primary publication · 12538456 (PubMed)
  4. Increased phospho-AKT (Ser(473)) expression in bronchial dysplasia: implications for lung cancer prevention studies. Tsao AS, McDonnell T, Lam S, Putnam JB, Bekele N, Hong WK, Kurie JM (2003) Cancer Epidemiol Biomarkers Prev 12(7): 660-4
    › Primary publication · 12869408 (PubMed)
  5. Evaluating the role of serine protease inhibition in the management of tumor micrometastases. Putnam JB, Royston D, Chambers AF, Dunbar S, Lemmer JH, Norman P, Travis E, Vaporciyan AA, Yang S, Zacharski LR (2003) Oncology (Williston Park) 17(10 Suppl 10): 9-30; quiz 31-2
    › Primary publication · 14606367 (PubMed)
  6. Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases. Milas I, Komaki R, Hachiya T, Bubb RS, Ro JY, Langford L, Sawaya R, Putnam JB, Allen P, Cox JD, McDonnell TJ, Brock W, Hong WK, Roth JA, Milas L (2003) Clin Cancer Res 9(3): 1070-6
    › Primary publication · 12631609 (PubMed)
  7. Treatment outcomes of resected esophageal cancer. Hofstetter W, Swisher SG, Correa AM, Hess K, Putnam JB, Ajani JA, Dolormente M, Francisco R, Komaki RR, Lara A, Martin F, Rice DC, Sarabia AJ, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA (2002) Ann Surg 236(3): 376-84; discussion 384-5
    › Primary publication · 12192324 (PubMed) · PMC1422591 (PubMed Central)
  8. Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. Swisher SG, Wynn P, Putnam JB, Mosheim MB, Correa AM, Komaki RR, Ajani JA, Smythe WR, Vaporciyan AA, Roth JA, Walsh GL (2002) J Thorac Cardiovasc Surg 123(1): 175-83
    › Primary publication · 11782772 (PubMed)
  9. Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases. Friedel G, Pastorino U, Ginsberg RJ, Goldstraw P, Johnston M, Pass H, Putnam JB, Toomes H, International Registry of Lung Metastases, London, England (2002) Eur J Cardiothorac Surg 22(3): 335-44
    › Primary publication · 12204720 (PubMed)
  10. Resection of advanced thoracic malignancies requiring cardiopulmonary bypass. Vaporciyan AA, Rice D, Correa AM, Walsh G, Putnam JB, Swisher S, Smythe R, Roth J (2002) Eur J Cardiothorac Surg 22(1): 47-52
    › Primary publication · 12103372 (PubMed)